Related Experiment Video
Updated: Jan 21, 2026

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
Published on: June 18, 2013
Abstract:
A phase I trial reported positive results for an antibody-drug conjugate that targets HER2-positive tumors. Trastuzumab duocarmazine, which kills tumor cells by causing DNA damage, induced partial responses in 33% of patients whose tumors were resistant to the approved antibody-drug conjugate trastuzumab emtansine. The drug caused fatigue, neutropenia, pneumonitis, and eye-related side effects.
Insights
A novel antibody-drug conjugate, trastuzumab duocarmazine, shows promise for HER2-positive tumors resistant to existing therapies. This DNA-damaging agent achieved partial responses in a phase I trial, indicating potential for new treatment options.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- A phase I clinical trial evaluated trastuzumab duocarmazine, an antibody-drug conjugate targeting HER2-positive tumors.
- This agent is designed to induce DNA damage in tumor cells for therapeutic effect.
Discussion:
- Trastuzumab duocarmazine demonstrated efficacy in patients with HER2-positive tumors resistant to trastuzumab emtansine.
- Partial responses were observed in 33% of these heavily pre-treated patients.
Key Insights:
- The study highlights the potential of trastuzumab duocarmazine as a treatment for HER2-positive cancers.
- DNA-damaging antibody-drug conjugates represent a viable therapeutic strategy for drug-resistant malignancies.
Outlook:
- Further clinical trials are warranted to confirm efficacy and safety in a larger patient population.
- Investigating combination therapies involving trastuzumab duocarmazine may enhance treatment outcomes.
More Related Videos
11:34Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
10:21Protocol for HER2 FISH Using a Non-cross-linking, Formalin-free Tissue Fixative to Combine Advantages of Cryo-preservation and Formalin Fixation
Published on: December 25, 2017
Related Concept Videos
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
Position-effect Variegation
Position and Displacement
Serial Position Effect
Anatomical Positions
The body is upright, facing forward, and standing erect.
The feet are parallel and flat on the floor.
The arms are hanging by the...
Position Vectors
For instance, we want to locate a point P(x, y, z) relative to the origin of coordinates O. In that case, we can define a position...